Y-90 selective internal radiation therapy and peptide receptor radionuclide therapy for the treatment of metastatic neuroendocrine tumors: combination or not?


Yilmaz E., Engin M. N. , Oezkan Z. G. , Kovan B. , Bueyuekkaya F., Poyanli A. , ...More

NUCLEAR MEDICINE COMMUNICATIONS, vol.41, no.12, pp.1242-1249, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 41 Issue: 12
  • Publication Date: 2020
  • Doi Number: 10.1097/mnm.0000000000001284
  • Title of Journal : NUCLEAR MEDICINE COMMUNICATIONS
  • Page Numbers: pp.1242-1249
  • Keywords: Lu-177-octreotate, Y-90 microspheres, neuroendocrine tumors, peptide receptor radionuclide therapy, selective internal radiation therapy, RADIOEMBOLIZATION, LU-177-DOTATATE, MICROSPHERES, EFFICACY, NETS

Abstract

Background